TY  - JOUR

T1  - Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial

JO  - AM HEART J

PY  - 2009/04/01

AU  - James S

AU  - Akerblom A

AU  - Cannon CP

AU  - Emanuelsson H

AU  - Husted S

AU  - Katus H

AU  - Skene A

AU  - Steg PG

AU  - Storey RF

AU  - Harrington R

AU  - Becker R et al

ED  - 

DO  - DOI: 10.1016/j.ahj.2009.01.003

VL  - 157

IS  - 4

SP  - 599

EP  - 605

Y2  - 2024/12/22

ER  -